Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-09-19

Clinical Trial Update: Ketamine for Combined Depression and Alcohol Use Disorder [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update examining ketamine for co-occurring depression and alcohol use disorder across Phase 1 and Phase 2, with the study currently not yet rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: University Hospital of North Norway | Conditions: Depression, Alcohol Use Disorder | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING